Cargando…
Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life
OBJECTIVE: The aim of this study was to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and to assess the impact of maternal IBD medication use on these outcomes. DESIGN: We performed a multicentre retrospective study in The Netherlands. Women...
Autores principales: | Kanis, Shannon Linda, Modderman, Sanne, Escher, Johanna C, Erler, Nicole, Beukers, Ruud, de Boer, Nanne, Bodelier, Alexander, Depla, Annekatrien C T.M, Dijkstra, Gerard, van Dijk, Anne-Baue Ruth Margaretha, Gilissen, Lennard, Hoentjen, Frank, Jansen, Jeroen M, Kuyvenhoven, Johan, Mahmmod, Nofel, Mallant-Hent, Rosalie C, van der Meulen-de Jong, Andrea E, Noruzi, Anahita, Oldenburg, Bas, Oostenbrug, Liekele E, Ter Borg, Pieter C.J., Pierik, Marieke, Romberg- Camps, Mariëlle, Thijs, Willem, West, Rachel, de Lima, Alison, van der Woude, C Janneke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223671/ https://www.ncbi.nlm.nih.gov/pubmed/33046558 http://dx.doi.org/10.1136/gutjnl-2019-319129 |
Ejemplares similares
-
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022) -
Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort
por: Wintjens, Dion, et al.
Publicado: (2020) -
Impact of timing of primary ileocecal resection on prognosis in patients with Crohn’s disease
por: Beelen, Evelien M J, et al.
Publicado: (2023) -
Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
por: Asscher, Vera E. R., et al.
Publicado: (2020) -
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
por: Biemans, Vince B C, et al.
Publicado: (2020)